WhiteOak Capital Pharma and Healthcare Fund - Growth - Direct Plan

NAV 13.09(0.61%)
Jan 31, 2025
WhiteOak Capital Pharma and Healthcare Fund - Growth - Direct Plan
AUM
₹282 Cr
Expense (%)
0.69
Turnover (%)
N/A
Benchmark
BSE SENSEX - TRI
Asset Quality
Large, Green
Differs from benchmark (%)
0.00

3Yr Rolling Returns(%)

Benchmark# : undefined
                                                                                                                                                            Benchmark# is
Loading...

Top 10 Holdings

Something went wrong. Please try again after sometime!
PortfolioCompare

FAQ : WhiteOak Capital Pharma and Healthcare Fund - Growth - Direct Plan

WhiteOak Capital Pharma and Healthcare Fund - Growth - Direct Plan has delivered CAGR and average rolling returns as follows :

1 Year 3 Year 5 Year 9 Year
CAGR(%) N/A N/A N/A N/A
Average Rolling Returns(%) N/A N/A N/A N/A

The Current NAV of WhiteOak Capital Pharma and Healthcare Fund - Growth - Direct Plan is ₹13.09.

It is better to invest in a fund with a longer track record as WhiteOak Capital Pharma and Healthcare Fund - Growth - Direct Plan cannot be assessed for consistency of out-performance. However, funds returns unlikely to be different than its benchmark NIFTY 500, as the Funds portfolio is similar to its benchmark.

WhiteOak Capital Pharma and Healthcare Fund - Growth - Direct Plan fund’s expense ratio is 0.69%

The process for redemption is

  • Give a request for redemption of the number of units or the amount you want. The request will be acknowledged.
  • You will get information about the redemption and the NAV at which redeemed.
  • The amount will be deposited in the designated bank account.

The AUM of WhiteOak Capital Pharma and Healthcare Fund - Growth - Direct Plan is currently ₹283 Crores.

The Top three stocks are Sun Pharma Inds., Divis Lab and Cipla and account for 21% of its portfolio. Top 5 and 10 stocks of fund account for 31% and 46% of fund’s portfolio respectively.

Top three sectors of WhiteOak Capital Pharma and Healthcare Fund - Growth - Direct Plan fund are Healthcare, Others and IT accounting for 97% of the total portfolio.

Funds Portfolio Quality is Somewhat Good. It has a large proportion of Green and Orange Stocks.Since this is a Equity - Sectoral Fund - Pharma & Health Care it is comparatively safer to invest in this fund. However, since it has not consistently outperformed its benchmark index on an average 3-year rolling returns basis it is not the most suitable fund for SIP.

The category of WhiteOak Capital Pharma and Healthcare Fund - Growth - Direct Plan Fund is Equity - Sectoral Fund - Pharma & Health Care.

Ramesh Mantri and Dheeresh Pathak manage the WhiteOak Capital Pharma and Healthcare Fund - Growth - Direct Plan Fund.

WhiteOak Capital Pharma and Healthcare Fund - Growth - Direct Plan current PE ratio is 62.06 and PB ratio is 8.13

The asset allocation of WhiteOak Capital Pharma and Healthcare Fund - Growth - Direct Plan is Stocks : 87.84%, Debt : 12.17% and Gold : 0%

The minimum SIP amount for WhiteOak Capital Pharma and Healthcare Fund - Growth - Direct Plan is ₹100.00 and minimum lumpsum is ₹500.00

The exit load for WhiteOak Capital Pharma and Healthcare Fund - Growth - Direct Plan is 1% on or before 1 months, Nil after 1 months

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Loading...
Hold on